Cargando…
Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer
PURPOSE: To evaluate the dosimetry of a six-channel high-dose-rate (HDR) applicator for treatment of esophageal cancer with respect to lateral directionality and heterogeneous media. MATERIAL AND METHODS: A computed tomography (CT)- and magnetic resonance imaging (MRI)-compatible esophageal applicat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170515/ https://www.ncbi.nlm.nih.gov/pubmed/34122572 http://dx.doi.org/10.5114/jcb.2021.106049 |
_version_ | 1783702261258518528 |
---|---|
author | Zhao, Anzi Gao, Shengqiang Greskovich, John Wilkinson, Douglas Allan |
author_facet | Zhao, Anzi Gao, Shengqiang Greskovich, John Wilkinson, Douglas Allan |
author_sort | Zhao, Anzi |
collection | PubMed |
description | PURPOSE: To evaluate the dosimetry of a six-channel high-dose-rate (HDR) applicator for treatment of esophageal cancer with respect to lateral directionality and heterogeneous media. MATERIAL AND METHODS: A computed tomography (CT)- and magnetic resonance imaging (MRI)-compatible esophageal applicator consisting of 2 inflatable portions (anchor and therapeutic balloons) with 6 longitudinal treatment catheters equally spaced circumferentially was constructed. Treatment plans were prepared using Oncentra 4.5 for various catheter loadings and target locations and sizes. Calculated dose distributions were compared to measured distributions obtained using film and a water phantom. Balloon inflations with water and with air were tested. RESULTS: TG-43 dose calculations matched measurements well when inflation balloons were filled with water. When air was used to inflate, model-based dose calculations (TG-186) improved the comparison with measurement. Several cases with simulated ring targets demonstrated better dose conformity to non-uniform targets compared to a single central catheter. Additionally, the use of this applicator compared to a single catheter, gave rise to considerable improvement in sparing non-target tissue. CONCLUSIONS: Lateral dose modulation is achievable with the applicator described in this work. The use of TG-186 dose calculation made a small improvement in heterogeneous media. |
format | Online Article Text |
id | pubmed-8170515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-81705152021-06-11 Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer Zhao, Anzi Gao, Shengqiang Greskovich, John Wilkinson, Douglas Allan J Contemp Brachytherapy Original Paper PURPOSE: To evaluate the dosimetry of a six-channel high-dose-rate (HDR) applicator for treatment of esophageal cancer with respect to lateral directionality and heterogeneous media. MATERIAL AND METHODS: A computed tomography (CT)- and magnetic resonance imaging (MRI)-compatible esophageal applicator consisting of 2 inflatable portions (anchor and therapeutic balloons) with 6 longitudinal treatment catheters equally spaced circumferentially was constructed. Treatment plans were prepared using Oncentra 4.5 for various catheter loadings and target locations and sizes. Calculated dose distributions were compared to measured distributions obtained using film and a water phantom. Balloon inflations with water and with air were tested. RESULTS: TG-43 dose calculations matched measurements well when inflation balloons were filled with water. When air was used to inflate, model-based dose calculations (TG-186) improved the comparison with measurement. Several cases with simulated ring targets demonstrated better dose conformity to non-uniform targets compared to a single central catheter. Additionally, the use of this applicator compared to a single catheter, gave rise to considerable improvement in sparing non-target tissue. CONCLUSIONS: Lateral dose modulation is achievable with the applicator described in this work. The use of TG-186 dose calculation made a small improvement in heterogeneous media. Termedia Publishing House 2021-05-12 2021-06 /pmc/articles/PMC8170515/ /pubmed/34122572 http://dx.doi.org/10.5114/jcb.2021.106049 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Original Paper Zhao, Anzi Gao, Shengqiang Greskovich, John Wilkinson, Douglas Allan Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
title | Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
title_full | Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
title_fullStr | Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
title_full_unstemmed | Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
title_short | Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
title_sort | pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170515/ https://www.ncbi.nlm.nih.gov/pubmed/34122572 http://dx.doi.org/10.5114/jcb.2021.106049 |
work_keys_str_mv | AT zhaoanzi preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer AT gaoshengqiang preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer AT greskovichjohn preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer AT wilkinsondouglasallan preclinicaldosimetryofanewsixchannelapplicatorforhighdoseratetreatmentofesophagealcancer |